期刊文献+

双核Pt(Ⅳ)配合物与Guanosine-5′-Monophosphate和Glutathione反应的核磁共振光谱研究(英文) 被引量:1

NMR Studies on Reactivity of Dinuclear Platinum(Ⅳ) Complex Towards Guanosine-5′-Monophosphate and Glutathione
下载PDF
导出
摘要 合成了一个新型的双核Pt(Ⅳ)配合物{[cis-Pt(NH3)2Cl(OH)2]2(4,4′-methylenedianiline)}(NO3)2(化合物1)及相应的15N标记化合物{[cis-Pt(15NH3)2Cl(OH)2]2(4,4′-methylenedianiline)}(NO3)2(化合物15N-1)。利用1HNMR和ESMS进行了结构表征,化合物15N-1的2D[1H,15N]HSQCNMR发现,该化合物在水溶液中存在同分异构体。2D[1H,15N]HSQCNMR技术跟踪了化合物15N-1与Guanosine-5′-Monophosphate(5′-GMP)和Glutathione(GSH)的反应。结果显示,5′-GMP能在0.5h内将化合物1还原,而GSH在6h以后才能够部分的将化合物1还原。化合物1所表现出来的反应性能将有利于提高其治疗效果和降低毒副作用。 A dinuclear Pt (IV) complex {[cis-Pt (NH3)2Cl (OH)212 (4,4' -methylene-dianiline)} (NO3)2 (compound 1) was synthesized by the oxidation of {[cis-Pt(NH3)2C1]2 (4,4'-methylenedianiline)}(NO3)2, a potent anti-tumor active Pt(ll) complex. The formation of compound 1 was verified by 1H NMR and ES-MS spectroscopy. Compound 1 shows good water solubility. The 15N-labelled compound 1 (15N-1) was synthesized in order to investigate the reactivity of compound 1 towards guanosine-5'-monophosphate(5'-GMP) and glutathione (GSH) by 2D [1H, 15N] HSQC NMR spectroscopy. It was revealed from the 2D [1H, 15N] HSQC NMR spectra that compound 1 could exist in different isomers in aqueous solution. The reactivity of 15N-1 towards 5'-GMP and GSH was followed by 1H NMR and 2D [1H, 15N] HSQC NMR spectroscopy. The Pt(IV) isomers of compound 1 can be fully reduced to Pt(ll) species by 5'- GMP within 0.5 h, while they can only be partly reduced by GSH after 6 h. The reduction products were compared to those of compound 1 and ascorbate incubated for 48 h. The unique reactivity of compound 1 may be desirable for achieving enhanced therapeutic effects and decreased toxic side effects.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2007年第7期1206-1212,共7页 Chinese Journal of Inorganic Chemistry
基金 国家自然科学基金资助项目(No.20231010)
关键词 抗肿瘤试剂 双核铂(Ⅳ)配合物 DNA Guanosine-5′-Monophosphate(5′-GMP) Glutathione(GSH) antitumor agent dinuclear platinum(Ⅱ/IV)complexes DNA guanosine-5'-monophosphate(5'-GMP) glutathione(GSH)
  • 相关文献

参考文献22

  • 1Boulikas T,Vougiouka M.Oncol.Rep.,2003,10:1663-1682
  • 2Pasini A,Zunino F,Angew.Chem.Int.Ed.Engl.,1987,26:615-624
  • 3Fuertes M A,Castilla J,Perez J M,et al.Anti-Cancer Agents,2002,2:539-551
  • 4Kelland L R.Drugs,2000,59:1-8
  • 5Dempek W,Voigt W,Grothey A,et al.Anti-Cancer Drugs,2000,11:225-236
  • 6Galanski M,Jakupec M A,Keppler B K Curr.Med.Chem.,2005,12:2075-2094
  • 7Mellish K J,Kelland L R,Harrap K R Br.J.Cancer,1993,68:240-250
  • 8Bramwell V H C,Crowther D,OMalley S,et al.Cancer Treat.Rep.,1985,69:409-416
  • 9Rahman A,Wolpert-DeFilippes M K,Goldin A,et al.Cancer Res.,1988,48:1745-1752
  • 10Ellis L A,Er H M,Hambley T W.Aust.J.Chem.,1995,48:793-806

同被引文献16

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部